Oncimmune Financial Statements From 2010 to 2024

Stocks . UK . 
Stock . Oncimmune Holdings plc
ONC Stock   15.20  0.45  3.05%   
Oncimmune Holdings financial statements provide useful quarterly and yearly information to potential Oncimmune Holdings plc investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Oncimmune Holdings financial statements helps investors assess Oncimmune Holdings' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Oncimmune Holdings' valuation are summarized below:
Gross Profit
1.5 M
Profit Margin
5.8608
Exchange Market
LSE - AIM
Market Capitalization
17 M
Enterprise Value Revenue
17.1644
There are over eighty-three available trending fundamental ratios for Oncimmune Holdings plc, which can be analyzed over time and compared to other ratios. Investors should ensure to check out all of Oncimmune Holdings' recent performance against the performance from 2010 to 2024 to make sure the company is sustainable down the road.

Oncimmune Holdings Total Revenue

1.42 Million

Check Oncimmune Holdings financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Oncimmune Holdings' main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.2 M, Interest Expense of 2.4 M or Selling General Administrative of 474.1 K, as well as many indicators such as . Oncimmune financial statements analysis is a perfect complement when working with Oncimmune Holdings Valuation or Volatility modules.
  
This module can also supplement various Oncimmune Holdings Technical models . Check out the analysis of Oncimmune Holdings Correlation against competitors.

Oncimmune Holdings Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets10.2 M9.7 M8.9 M
Slightly volatile
Short and Long Term Debt Total5 M6.1 M5 M
Slightly volatile
Other Current Liabilities634.1 K830.3 K598 K
Pretty Stable
Total Current Liabilities1.6 M1.6 M2.9 M
Slightly volatile
Property Plant And Equipment Net617.1 K679.6 K552.2 K
Slightly volatile
Accounts Payable187.9 K197.8 K446.4 K
Slightly volatile
Cash5.3 M3.7 M4.6 M
Pretty Stable
Non Current Assets Total2.6 M3.3 M2.3 M
Slightly volatile
Cash And Short Term Investments5.3 M3.7 M4.6 M
Pretty Stable
Common Stock Total Equity766.8 K730.2 K422.7 K
Slightly volatile
Liabilities And Stockholders Equity10.2 M9.7 M8.9 M
Slightly volatile
Other Current Assets217.4 K228.8 K666.9 K
Pretty Stable
Other Stockholder Equity39.1 M49.1 M36.2 M
Slightly volatile
Total Liabilities7.1 M8.9 M6.3 M
Slightly volatile
Property Plant And Equipment Gross642.7 K1 M593.9 K
Slightly volatile
Total Current Assets7.5 M6.4 M6.6 M
Slightly volatile
Common Stock463.7 K852.1 K425.5 K
Slightly volatile
Common Stock Shares Outstanding62.2 M83.4 M58 M
Slightly volatile
Net Receivables1.6 M2.2 M1.4 M
Slightly volatile
Property Plant Equipment1.9 M1.8 M741 K
Slightly volatile
Other Liabilities2.6 M2.4 M940.1 K
Slightly volatile
Other Assets1.091.15280.1 K
Pretty Stable
Deferred Long Term Liabilities379.3 K225.4 K235.4 K
Slightly volatile
Intangible Assets527.7 K555.5 K863.9 K
Slightly volatile
Net Invested Capital6.9 M5.2 M7.1 M
Pretty Stable
Non Current Liabilities Other1.2 M1.5 M713.8 K
Slightly volatile
Good Will1.3 M1.4 M1.5 M
Slightly volatile
Capital Stock746.9 K852.1 K670.5 K
Slightly volatile
Current Deferred Revenue167.6 K176.4 K1.1 M
Pretty Stable
Capital Lease Obligations112 K117.9 K801.8 K
Slightly volatile

Oncimmune Holdings Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization1.2 M1.1 M398.2 K
Slightly volatile
Interest Expense2.4 M2.3 M757.3 K
Slightly volatile
Selling General Administrative474.1 K499.1 K3.7 M
Very volatile
Total Revenue1.4 M1.3 M1.3 M
Pretty Stable
Other Operating Expenses7.5 M6.2 M6.5 M
Slightly volatile
Research Development1.3 M1.4 M1.2 M
Slightly volatile
Cost Of Revenue707.1 K414 K564.4 K
Slightly volatile
Total Operating Expenses6.8 M5.8 M6 M
Slightly volatile
Reconciled Depreciation653.7 K1.1 M432.5 K
Slightly volatile
Selling And Marketing Expenses2.7 M3 M3.3 M
Slightly volatile

Oncimmune Holdings Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow1.6 M1.6 M4.1 M
Pretty Stable
Depreciation1.2 M1.1 M480.4 K
Slightly volatile
Capital Expenditures33.9 K35.6 K222.8 K
Pretty Stable
End Period Cash Flow5.3 M3.7 M4.5 M
Slightly volatile
Sale Purchase Of Stock8.4 M13.2 M8.3 M
Slightly volatile
Other Cashflows From Investing Activities4.3 K4.5 K47.1 K
Slightly volatile

Oncimmune Fundamental Market Drivers

Forward Price Earnings73.5294
Cash And Short Term Investments3.2 M

About Oncimmune Holdings Financial Statements

Oncimmune Holdings stakeholders use historical fundamental indicators, such as Oncimmune Holdings' revenue or net income, to determine how well the company is positioned to perform in the future. Although Oncimmune Holdings investors may analyze each financial statement separately, they are all interrelated. For example, changes in Oncimmune Holdings' assets and liabilities are reflected in the revenues and expenses on Oncimmune Holdings' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Oncimmune Holdings plc. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue176.4 K167.6 K
Total Revenue1.3 M1.4 M
Cost Of Revenue414 K707.1 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
TITANTitan Company Limited
UUnity Software
PAYCPaycom Soft

Other Information on Investing in Oncimmune Stock

Oncimmune Holdings financial ratios help investors to determine whether Oncimmune Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Oncimmune with respect to the benefits of owning Oncimmune Holdings security.
Balance Sheet
Statement
Details
Profit & Loss
Statement
Details
Cash Flow
Statement
Details
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY